Cancer
📧 Sign up to get email alerts when something new happens for Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-11-25Clinical Trial Update: A Study to Assess the Potential Effects of Rifampin on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies [Phase 1]
This completed Phase 1 trial assessed whether Rifampin changes the pharmacokinetics of trabectedin in patients with advanced malignancies to…
-
CLINICAL_TRIALS trial_result · 2014-11-25Clinical Trial Update: Efficacy of Tobacco Quitline for Cancer Survivors [NA]
This completed clinical trial evaluated the efficacy of a tobacco quitline in helping cancer survivors quit smoking.
-
CLINICAL_TRIALS trial_result · 2014-11-19Clinical Trial Update: Dexamethasone for the Prophylaxis of Pain Flare Study [Phase 1]
This document reports the completion of a Phase 1 trial evaluating dexamethasone for the prophylaxis of pain flare in cancer patients.
-
CLINICAL_TRIALS trial_result · 2014-11-18Clinical Trial Update: A Phase I/II Dose Escalation Study Using Extracranial Stereotactic Radiosurgery to Control Pain [NA]
This Phase I/II dose-escalation trial evaluated extracranial stereotactic radiosurgery to control pain in patients with metastatic cancer; t…
-
CLINICAL_TRIALS research · 2014-11-18Clinical Trial Update: A Qualitative Study Into How Patients Deal With Chemotherapy-related Side Effects at Home
This clinical trial update reports a qualitative study examining how cancer patients manage chemotherapy-related side effects at home.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2014-11-14Clinical Trial Update: Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: Continuous Infusion for 10 Days [Phase 1]
A Phase 1 study of the SS1(dsFv)-PE38 (SS1P) anti-mesothelin immunotoxin in advanced malignancies was withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-11-13Clinical Trial Update: Radiation Dosimetry, Metabolism, Pharmacokinetics, Safety and Tolerability and PET Imaging With BAY94-9392 in Healthy Volunteers and Patients With Cancer or Inflammation [Phase 1]
Phase 1 study evaluating BAY94-9392 PET imaging in healthy volunteers and patients with cancer or inflammatory disease, assessing radiation …
-
CLINICAL_TRIALS trial_result · 2014-11-13Clinical Trial Update: Exploration of Tumor Accumulation of BAY94-9392 in Patients With Cancer [Phase 1]
Phase 1 clinical trial investigating tumor accumulation of BAY94-9392 in cancer patients has completed. The update summarizes observations o…
-
CLINICAL_TRIALS trial_result · 2014-11-05Clinical Trial Update: Optimal Transfusion in Anaemic Cancer Patients Treated With Chemotherapy (HaemOPtimal) [Phase 2]
HaemOPtimal is a Phase 2 trial assessing optimal transfusion strategies for anaemic cancer patients undergoing chemotherapy; the study has b…
-
CLINICAL_TRIALS trial_result · 2014-11-03Clinical Trial Update: Traditional African Healing Ceremony in a U.S. Population [NA]
A completed clinical trial evaluating the effects of a Traditional African healing ceremony in a U.S. population with Chronic Fatigue Syndro…
-
CLINICAL_TRIALS withdrawal · 2014-10-29Clinical Trial Update: Cotinine Feedback as an Intervention to Change Parental/Caregiver Smoking Behavior Around Children With Cancer [Phase 2]
A Phase 2 clinical trial evaluating cotinine feedback to influence parental/caregiver smoking around children with cancer has been withdrawn…
-
CLINICAL_TRIALS trial_result · 2014-10-22Clinical Trial Update: A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors [Phase 1]
Phase 1 dose-escalation study of iniparib as a single agent and in combination for solid tumors; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2014-10-21Clinical Trial Update: XL999 Administered Intravenously to a Subject With Advanced Malignancies
XL999 was administered intravenously to a subject with advanced malignancies; the trial entry is no longer available.
-
CLINICAL_TRIALS trial_result · 2014-10-10Clinical Trial Update: Impact on Quality of Life by Moxibustion in Chemotherapy for Cancer [NA]
A ClinicalTrials.gov update describes a study evaluating whether moxibustion improves quality of life for cancer patients undergoing chemoth…
-
CLINICAL_TRIALS trial_result · 2014-10-08Clinical Trial Update: Feasibility Study on the Effect of Complementary Methods as Supportive Interventions for Parents of Children With Cancer [NA]
A completed feasibility study evaluating complementary methods as supportive interventions for parents of children with cancer.
-
CLINICAL_TRIALS withdrawal · 2014-10-07Clinical Trial Update: E-health Intervention for Cancer Survivors 2.0 [Phase 1]
A Phase 1 clinical trial of an e-health intervention for cancer survivors has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-10-01Clinical Trial Update: Open Label Regorafenib Study to Evaluate Cardiovascular Safety Parameters, Tolerability, and Anti-tumor Activity [Phase 1]
An open-label Phase 1 study of regorafenib evaluated cardiovascular safety, tolerability, and anti-tumor activity in cancer patients and has…
-
CLINICAL_TRIALS trial_result · 2014-10-01Clinical Trial Update: Clinical Study to Evaluate the Maximum Tolerated Dose of BAY79-4620 Given Every 2 Weeks to Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 trial update reports the termination of a study evaluating BAY79-4620 administered every two weeks in patients with advanced solid…
-
FDA approval · 2014-09-25FDA Approved: FLUDEOXYGLUCOSE F 18 — Original Application (Massachusetts General Hospital)
The FDA granted original approval for Fluorodeoxyglucose F-18, a radiopharmaceutical from Massachusetts General Hospital, for use with PET i…
-
CLINICAL_TRIALS trial_result · 2014-09-17Clinical Trial Update: An Efficacy and Safety Study of Low-dose Transdermal Therapeutic System (TTS)-Fentanyl D-Trans in Taiwan Participants With Cancer Pain [Phase 4]
Phase 4 trial update reporting efficacy and safety of a low-dose fentanyl transdermal system in Taiwan patients with cancer-related pain.
-
CLINICAL_TRIALS trial_result · 2014-09-16Clinical Trial Update: Improving Clinician Communication Skills (ICCS) [Phase 3]
Phase 3 trial evaluating a program to improve clinician communication skills has completed. The ICCS study is sponsored by the University of…
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV [Phase 2]
Phase 2 trial evaluating the immunogenicity of Fluzone High-Dose influenza vaccine in pediatric patients with cancer or HIV; results were po…
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: Intervention Study of Communication in Oncologist-Patient Encounters [NA]
The document is a completed update on an intervention trial examining communication in oncologist-patient encounters for individuals with ad…
-
CLINICAL_TRIALS trial_result · 2014-09-11Clinical Trial Update: Phase I, Pharmacokinetic, Pharmacodynamic Trial of PTK787 and Paclitaxel in Combination for Advanced Solid Tumors [Phase 1]
Phase I pharmacokinetic/pharmacodynamic study evaluating the combination of PTK787 (Vatalanib) with Paclitaxel in patients with advanced sol…
-
CLINICAL_TRIALS trial_result · 2014-09-09Clinical Trial Update: Bibliotherapy for Patients With Cancer [NA]
Completed clinical trial evaluating bibliotherapy for cancer patients.